Navigation path

Community Register of medicinal products

List of referrals for human medicinal products

Tazocin and associated names

Product name: Tazocin and associated names
Also marketed in the EU under the name(s): Tazobac, Tazocel, Tazocilline, Tazocin, Tazonam
INN: piperacillin-tazobactam
Indication: Tazocin is indicated for the treatment of the following infections
- Adults and adolescents
  • Severe pneumonia including hospitalacquired and ventilatorassociated pneumonia

  • Complicated urinary tract infections (including pyelonephritis)

  • Complicated intraabdominal infections

  • Complicated skin and soft tissue infections (including diabetic foot infections)

    • Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.
    Tazocin may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection.
    - Children 2 to 12 years of age
  • Complicated intra-abdominal infections

    • Tazocin may be used in the management of neutropenic children with fever suspected to be due to a bacterial infection.
    Marketing Authorisation Holder: Pfizer Limited

     

    European Commission proceduresGoto top of the page

    Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
    23/02/2011 Referral EMEA/H/A-30/1149 (2011)1196 of 21/02/2011